Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Annals of Hematology|January 10, 2025
Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experienceFelicitas Schulz, Claudia Roggenbuck, Andrea Kündgen, et al.
Leukemia & Lymphoma|December 11, 2007
Escalation therapy with bortezomib, dexamethasone and bendamustine for patients with relapsed or refractory multiple myelomaRoland Fenk, Mark Michael, Fabian Zohren, et al.
Cancer Immunity|December 18, 2003
Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2Claudia Wagner, Frank Neumann, Boris Kubuschok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximabJörg Thomas Bittenbring, Frank Neumann, Bettina Altmann, et al.
Cancer Immunology, Immunotherapy : CII|September 15, 2012
T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16Lisa M Pörtner, Kathrin Schönberg, Maryam Hejazi, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2009
Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomasCarsten Zwick, Gerhard Held, Vera Hammermeister, et al.
Alzheimer'S Research & Therapy|October 20, 2023
A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD miceDeebika Balu, Ana C Valencia-Olvera, Austin Nguyen, et al.
Blood|June 4, 2011
Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial systemThomas Luft, Sascha Dietrich, Christine Falk, et al.
Pageof 12